Landgraf G, Desheva Y A, Rudenko L G
Federal State Budgetary Educational Institution of Higher Professional Education "St. Petersburg State University", St. Petersburg, Russian Federation.
Federal State Budget Scientific Institution "Institute of Experimental Medicine", St. Petersburg, Russian Federation.
MethodsX. 2021 Jul 4;8:101442. doi: 10.1016/j.mex.2021.101442. eCollection 2021.
We applied a one-step reverse transcriptase real-time PCR (rRT-PCR) analysis using TaqMan technique to evaluate the infectious titers of vaccine strains containing in trivalent live influenza vaccines (LAIVs). The cold-adapted reassortant influenza viruses A/H1N1 pdm09, A/H3N2, B/Yamagata and B/Victoria, included in the composition of the LAIV in 2015-2016, 2017-2018 and 2018-2019 flu season were studied for reproductive activity in MDCK cells as part of a mono-vaccine and tri-vaccine. For this we have developed a set of specific primers and probes. Method validation was performed using ELISA-test after mouse monoclonal antibodies to hemagglutinin (HA) staining of MDCK monolayer. Influenza B viruses B/Yamagata and B/Victoria were studied in MDCK cells in mono-infection and coinfection with different multiplicity of infection (MOI) using quantitative rRT-PCR.•RT-PCR analysis was adjusted to assess the growth characteristics of cold-adapted reassortant influenza viruses in MDCK cell line. The greatest suppression in the composition of the tri-vaccine was exposed to the H1N1 pdm09 LAIV component.•Influenza B viruses are least suppressed in trivalent LAIV. Influenza viruses B/Yamagata and B/Victoria reproduced as part of a mixed preparation not lower, if not better than as a mono-preparation at an MOI of 0.1. At an MOI of 0.01, the reproduction of both B/Yamagata and B/Victoria in the mixture was reduced compared to mono-vaccine.•The interference of trivalent LAIV vaccine viruses in MDCK cells was minimal at low dilutions. This indicates that it is undesirable to reduce the titers of vaccine viruses, including at the stages of transportation and storage of LAIV.
我们采用TaqMan技术进行一步法逆转录酶实时荧光定量PCR(rRT-PCR)分析,以评估三价流感活疫苗(LAIVs)中所含疫苗株的感染滴度。对2015 - 2016年、2017 - 2018年和2018 - 2019年流感季节LAIV成分中包含的冷适应重配流感病毒A/H1N1 pdm09、A/H3N2、B/山形和B/维多利亚作为单疫苗和三疫苗的一部分,在MDCK细胞中的增殖活性进行了研究。为此,我们开发了一组特异性引物和探针。使用针对MDCK单层血凝素(HA)染色的小鼠单克隆抗体进行ELISA试验来进行方法验证。采用定量rRT-PCR在MDCK细胞中对B/山形和B/维多利亚流感病毒进行单感染和不同感染复数(MOI)的共感染研究。•调整RT-PCR分析以评估冷适应重配流感病毒在MDCK细胞系中的生长特性。三价疫苗成分中抑制作用最大的是H1N1 pdm09 LAIV成分。•B型流感病毒在三价LAIV中受到的抑制最小。B/山形和B/维多利亚流感病毒作为混合制剂的一部分增殖时,在MOI为0.1时,即使不比单制剂更好,也不会更低。在MOI为0.01时,与单疫苗相比,混合物中B/山形和B/维多利亚的增殖均降低。•三价LAIV疫苗病毒在低稀释度下对MDCK细胞的干扰最小。这表明降低疫苗病毒滴度是不可取的,包括在LAIV运输和储存阶段。